Dako Denmark A/S
Dako was established in 1966, when Danish medical doctor Niels Harboe founded the company and played a pioneering role in the standardizing antibodies for clinical use; since then the company has grown into a global business with a leading position in the pathology segment of the in vitro diagnostics industry.
Today, Dako is headquartered in Denmark with manufacturing and research sites in Denmark and the United States and more than 1,200 committed employees. Dako’s reagents, instruments and software are sold in more than 100 markets.
In 2012, Dako became part of Agilent Technologies – the world’s premier measurement company. Agilent has a global footprint of more than 20,000 employees in more than 100 countries – a global reach that is now benefiting Dako.
Dako’s strong focus on anatomic pathology and its relentless fight against cancer is accompanied by a separate and focused business division targeting retail and OEM customers – Dako Reagent Partnership Division.
DAKO REAGENT PARTNERSHIP DIVISION
Reagent Partnership offers a comprehensive product portfolio as well as a large, world-wide network of distributors to ensure prompt access and support to partners and customers around the globe.
Reagent Partnership has two major product categories:
Specific Proteins and Flow Cytometry.